FDA Drug recall D-0314-2024
Febuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217
- FDA Drug
- Class II
- terminated
- Published 2024-02-14
On 2024-02-14 the FDA classified a Class II recall of Febuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217 by Amerisource Health Services, citing CGMP Deviations.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0314-2024 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2024-01-25 |
| Published | 2024-02-14 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Amerisource Health Services |
| Distribution | US |
Product
Febuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-538-21, NDC Unit dose 60687-538-11
Reason
CGMP Deviations
Identifiers
| ndc | 60687-538-11 |
|---|---|
| ndc | 60687-538-21 |
| code_info | Lot # 1015033, exp. 06/30/2025; 1016409, exp. 08/31/2025 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0314-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.